Analysis of the Efficiency of Microencapsulated Sustained-Release Form of Naloxone on the Experimental Model of Fentanyl Poisoning


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We compared samples of microencapsulated naloxone prepared by using spray drying technique. 2-Hydroxypropyl-β-cyclodextrin, sodium alginate, polycaprolactone, and carboxymethyl cellulose were used as the carriers. It was found that the combination of naloxone with sodium alginate was characterized by the highest naloxone content in the matrix and the lowest release rate (100% release time was 60 min). Using the model of respiratory disturbances caused by 10 ED50 fentanyl (anesthetic effect), we studied the effects of naloxone—sodium alginate complex on the dynamics of CO2 concentration in the expired air. It was shown that treatment with the developed microencapsulated naloxone after fentanyl injection allowed reducing the therapeutic dose of the antagonist by more than 2 times and eliminated the necessity of repeated injections.

Sobre autores

N. Vengerovich

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Autor responsável pela correspondência
Email: ng@vengerovich.ru
Rússia, Moscow

M. Yudin

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Rússia, Moscow

V. Bykov

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Rússia, Moscow

A. Nikiforov

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Rússia, Moscow

O. Aleshina

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Rússia, Moscow

A. Kuz’min

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Rússia, Moscow

T. Ustinova

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Rússia, Moscow

S. Gadzikovskii

Silver-Farm Innovative Pharmaceutical Companyss

Email: ng@vengerovich.ru
Rússia, St. Petersburg


Declaração de direitos autorais © Springer Science+Business Media, LLC, 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies